Latest On Hisamitsu Pharmaceutical Co., Inc (HTSUF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-02-26 05:08 EST | Dividend | A dividend of $41.75 has been announced on Apr 10, 2020. It will be paid Nov 30, -0001 with an ex-dividend date of Feb 26, 2021. | Neutral |  |
| 2021-02-22 14:22 EST | News | Hisamitsu's Noven submits dextroamphetamine transdermal system NDA for ADHD | N/A | |
| 2021-01-14 17:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-04 18:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 23:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 02:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-13 15:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-09 19:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-30 19:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 08:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 17:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 03:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 15:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 08:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 22:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 19:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-14 17:40 EST | News | Noven Pharma's asenapine patch available in U.S. for schizophrenia | N/A | |
| 2020-04-12 10:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 23:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 23:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 22:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 06:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 05:11 EST | Dividend | A dividend of $41.5 has been announced on Apr 10, 2019. It will be paid Jan 1, 1970 with an ex-dividend date of Feb 28, 2020. | Neutral | |
| 2020-02-28 00:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 02:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-21 01:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 01:52 EST | Financials | Company financials have been released. | Neutral | |
About Hisamitsu Pharmaceutical Co., Inc (HTSUF):
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. The company provides analgesic / anti-inflammatory patches; athlete's foot / ringworm remedy products; allergy-only rhinitis drugs; eye drops; high cholesterol improving drugs; acne remedies; cooling sheets; and supporters for knee, waist, elbow, calf and ankle. It also provides cooling sprays; bactericidal antibacterial spray and deodorant spray; ship fixing sheet; adhesive plasters for magnetic products; skin care products; sweat sheet; massage roller gel and oil spray; thermal equipment, and dietary supplements. The company offers its products under the Salon pass, Salonship, Air Salon Pass, Fatus, Butena Rock, Allegra, Direct pasting, Choleston, Life Cera, Deco Deco Cool, Children Robin Eye Plus. Eye cool, MSM, and other brand names. It sells its products in North America, Central and South America, Asia, Oceania, the Middle East, Africa, and Europe. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
General
- Name Hisamitsu Pharmaceutical Co., Inc
- Symbol HTSUF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 2,745
- Fiscal Year EndFebruary
- Web URLhttp://www.hisamitsu.co.jp
Valuation
- Trailing PE 19.78
- Price/Sales (Trailing 12 Mt.) 2.62
- Price/Book (Most Recent Quarter) 1.47
- Enterprise Value Revenue 0.03
- Enterprise Value EBITDA 0.31
Financials
- Most Recent Quarter 2020-11-30
- Profit Margin 7%
- Return on Assets 3%
- Return on Equity 4%
- Revenue Per Share $0
- Gross Profit 87.6 billion
- Quarterly Earnings Growth -21.8%
Highlights
- Market Capitalization 5.2 billion
Share Statistics
- Shares Outstanding 81.66 million
- Shares Float 76.78 million
- % Held by Insiders 2827%
- % Held by Institutions 35.21%
Technicals
- Beta 0.69
- 52 Week High $42.05
- 52 Week Low $42.05
- 50 Day Moving Average 42.05
- 200 Day Moving Average 42.05
Dividends
- Forward Annual Dividend Rate $0.77
- Forward Annual Dividend Yield 1.83%
- Payout Ratio 4683%
- Dividend Date N/A
- ExDividend Date 2021-02-25
- Dividend Per Share $0.77
- Dividend Yield 0%
Hisamitsu Pharmaceutical Co., Inc (HTSUF) Dividend Calendar:
Hisamitsu Pharmaceutical Co., Inc pays out 4683% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Hisamitsu Pharmaceutical Co., Inc (HTSUF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-11-30 | 2020-11-30 | $N/A | $0.24 | ||
| 2020-08-31 | 2020-11-30 | $N/A | $0.24 | ||
| 2020-05-31 | 2020-08-31 | $24.88 billion | $0.41 | $30.90 | -98.66% |
| 2020-02-29 | 2020-05-31 | $N/A | $0.01 | ||
| 2019-11-30 | 2020-02-29 | $35.68 billion | $0.37 | ||
| 2019-08-31 | 2019-11-30 | $34.17 billion | $0.88 | ||
| 2019-05-31 | 2019-08-31 | $29.23 billion | $0.64 | ||
| 2019-02-28 | 2019-05-31 | $40.83 billion | $0.21 | ||
| 2018-11-30 | 2019-02-28 | $33.19 billion | $0.63 | ||
| 2018-08-31 | 2018-11-30 | $3.92 billion | $0.44 | ||
| 2018-05-31 | 2018-08-31 | $5.26 billion | $0.61 | $57.40 | -98.93% |
| 2018-02-28 | 2018-05-31 | $35.31 million | $0.38 | ||
| 2017-11-30 | 2018-02-28 | $5.77 billion | $0.37 | ||
| 2017-08-31 | 2017-11-30 | $37.38 billion | $0.68 | ||
| 2017-05-31 | 2017-08-31 | $36.08 billion | $0.62 | ||
| 2017-02-28 | 2017-05-31 | $36.2 billion | $0.40 | ||
| 2016-11-30 | 2017-02-28 | $0.22 | |||
| 2016-08-31 | 2016-11-30 | $0.93 | |||
| 2016-05-31 | 2016-08-31 | $0.54 | $61.10 | -99.12% | |
| 2016-02-29 | 2016-05-31 | $0.48 | |||
| 2015-11-30 | 2016-02-29 | $0.26 | |||
| 2015-08-31 | 2015-11-30 | $0.57 | |||
| 2015-05-31 | 2015-08-31 | $0.56 | $53.70 | -98.95% | |
| 2015-02-28 | 2015-05-31 | $0.33 | |||
| 2014-11-30 | 2015-02-28 | $0.42 | |||
| 2014-08-31 | 2014-11-30 | $0.48 | $0.00 | ||
| 2014-05-31 | 2014-08-31 | $0.63 | $0.00 | ||
| 2014-02-28 | 2014-05-31 | $0.46 | $0.00 | ||
| 2013-11-30 | 2014-02-28 | $0.25 | $0.00 | ||
| 2013-08-31 | 2013-11-30 | $0.63 | $0.00 | ||
| 2013-05-31 | 2013-08-31 | $0.73 | $0.00 | ||
| 2013-02-28 | 2013-05-31 | $0.87 | $0.00 | ||
| 2012-11-30 | 2013-02-28 | $0.48 | $0.00 | ||
| 2012-08-31 | 2012-11-30 | $0.80 | $0.00 | ||
| 2012-05-31 | 2012-08-31 | $0.85 | $0.00 | ||
| 2012-02-29 | 2012-05-31 | $0.54 | $0.00 | ||
| 2011-11-30 | 2012-02-29 | $0.54 | $0.00 | ||
| 2011-08-31 | 2011-11-30 | $1.14 | $0.00 | ||
| 2011-05-31 | 2011-08-31 | $0.66 | $0.00 | ||
| 2011-02-28 | 2011-05-31 | $0.40 | $0.00 | ||
| 2010-11-30 | 2011-02-28 | $0.60 | $0.00 |
Hisamitsu Pharmaceutical Co., Inc (HTSUF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Nov 30 2020 | Aug 31 2020 | May 31 2020 | Mar 31 2020 | Feb 29 2020 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | 418 million | 418 million | N/A |
| Selling General Administrative | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | 15.21 billion | 15.21 billion | N/A |
| Ebit | N/A | N/A | 420 million | 420 million | N/A |
| Operating Income | N/A | N/A | 1.08 billion | 1.08 billion | N/A |
| Income Tax Expense | 707 million | 1.37 billion | 334 million | 334 million | 1.32 billion |
| Total Revenue | N/A | N/A | 24.88 billion | 24.88 billion | N/A |
| Cost of Revenue | N/A | N/A | 9.67 billion | 9.67 billion | N/A |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | N/A |
| Net Income From Continuing Operations | N/A | N/A | 84 million | 84 million | N/A |
| Net Income Applicable to Common Shares | 2.03 billion | 3.58 billion | 113 million | 113 million | 3.27 billion |
Balance Sheet:
| Date | Nov 30 2020 | Aug 31 2020 | May 31 2020 | Mar 31 2020 | Feb 29 2020 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 47.38 billion | N/A | N/A |
| Total Stockholder Equity | N/A | N/A | 248.33 billion | 4.53 billion | N/A |
| Other Current Liabilities | 21.83 billion | 21.57 billion | 20.03 billion | 248.33 billion | N/A |
| Total Assets | N/A | N/A | 297.09 billion | N/A | N/A |
| Common Stock | 8.47 billion | 8.47 billion | 8.47 billion | 20.03 billion | 8.47 billion |
| Other Current Assets | 10.54 billion | 6.93 billion | 4.53 billion | 8.47 billion | N/A |
| Retained Earnings | 229.85 billion | 231.23 billion | 227.65 billion | 227.65 billion | 230.93 billion |
| Other Liabilities | 15.25 billion | 14.99 billion | 15.98 billion | 15.98 billion | 15.1 billion |
| Other Assets | 8.26 billion | 9.1 billion | 9.24 billion | 1000000 | 9.71 billion |
| Cash | N/A | N/A | 101.16 billion | 101.16 billion | N/A |
| Total Current Liabilities | 30.26 billion | 30.71 billion | 31.05 billion | 31.05 billion | N/A |
| Other Stockholder Equity | 20.1 billion | 20.88 billion | 21.62 billion | 21.62 billion | 19.33 billion |
| Property, Plant & Equipment | 37.15 billion | 38.15 billion | 37.97 billion | 37.97 billion | 38.6 billion |
| Total Current Assets | 196.46 billion | 197.45 billion | 195.78 billion | 195.78 billion | N/A |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 247.94 billion | 249.97 billion | 246.76 billion | 246.76 billion | 247.81 billion |
| Short Term Investments | N/A | N/A | 34 billion | 34 billion | N/A |
| Long Term Debt | N/A | N/A | 349 million | 349 million | N/A |
| Inventory | 19.99 billion | 19.51 billion | 18.2 billion | 18.2 billion | N/A |
| Accounts Payable | 6.9 billion | 6.8 billion | 8.81 billion | 8.81 billion | N/A |
Hisamitsu Pharmaceutical Co., Inc (HTSUF) Chart:
Hisamitsu Pharmaceutical Co., Inc (HTSUF) News:
Below you will find a list of latest news for Hisamitsu Pharmaceutical Co., Inc (HTSUF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Hisamitsu Pharmaceutical Co., Inc (HTSUF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Hisamitsu Pharmaceutical Co., Inc (HTSUF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|